Literature DB >> 11258059

[Buruli ulcer: risk of bone involvement! Apropos of 33 cases observed in Benin].

V Lagarrigue1, F Portaels, W M Meyers, J Aguiar.   

Abstract

Skin lesions are the best known manifestations of Mycobacterium ulcerans infection. However osteomyelitis is not uncommon with incidences as high as 14 p. 100 having been reported. The literature contains little specific data on bone lesions. This report describes a series of 33 patients presenting bacteriologically and/or histologically confirmed osteomyelitis induced by Mycobacterium ulcerans. In 64 p. 100 of cases, bone involvement occurred within the first year of the disease. In 70 p. 100 of cases, the site of involvement was on extremities. The median number of sites per patient was two (range, 1 to 5) and the number of bones was not correlated with the duration of disease. Overall, 41 p. 100 of bone sites occurred locally beneath skin lesions and 59 p. 100 were distant metastases. Osteomyelitis was associated with other germs in only 16 p. 100 of cases and superinfection was not a prerequisite for development of bone involvement. Clinical manifestations were usually low-grade with non-inflammatory, slightly painful local mass. The patient's general health status was unaffected in 79 p. 100. Histological examination allowed identification of the type of bone lesions induced by Mycobacterium ulcerans. For the first time, bone biopsy specimens were cultured. Based on bacteriological and histological findings, several postulations can be made about underlying pathophysiological mechanisms. The role of Buruli toxin is dealt with in the discussion.

Entities:  

Mesh:

Year:  2000        PMID: 11258059

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  21 in total

1.  Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).

Authors:  F Portaels; J Aguiar; M Debacker; C Steunou; C Zinsou; A Guédénon; W M Meyers
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.

Authors:  Ghislain Emmanuel Sopoh; Ange Dodji Dossou; Luc Valère Brun; Yves Thierry Barogui; Jean Gabin Houézo; Dissou Affolabi; Séverin Y Anagonou; Roch Christian Johnson; Luc Kestens; Françoise Portaels
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

3.  Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.

Authors:  Martinha S Oliveira; Alexandra G Fraga; Egídio Torrado; António G Castro; João P Pereira; Adhemar Longatto Filho; Fernanda Milanezi; Fernando C Schmitt; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

5.  Effects of decontamination, DNA extraction, and amplification procedures on the molecular diagnosis of Mycobacterium ulcerans disease (Buruli ulcer).

Authors:  Dissou Affolabi; N'Dira Sanoussi; Koen Vandelannoote; Mathieu Odoun; Frank Faïhun; Ghislain Sopoh; Séverin Anagonou; Françoise Portaels; Miriam Eddyani
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

6.  Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease.

Authors:  F Portaels; J Aguiar; M Debacker; A Guédénon; C Steunou; C Zinsou; W M Meyers
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).

Authors:  Kapay Kibadi; Marleen Boelaert; Alexandra G Fraga; Makanzu Kayinua; Adhemar Longatto-Filho; Jean-Bedel Minuku; Jean-Baptiste Mputu-Yamba; Jean-Jacques Muyembe-Tamfum; Jorge Pedrosa; Jean-Jacques Roux; Wayne M Meyers; Françoise Portaels
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

8.  Surgical Management of Chronic Wounds in a Buruli Ulcer Endemic Area in Central Africa.

Authors:  Marc Leroy Guifo; Agnes Essiene; Marie Ngo Nsoga; Ibrahima Farikou; Eone Daniel Handy; Ernest NjihTabah
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

9.  Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice.

Authors:  Laurent Marsollier; Nadine Honoré; Pierre Legras; Anne Lise Manceau; Henri Kouakou; Bernard Carbonnelle; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 10.  Buruli ulcer disease: prospects for a vaccine.

Authors:  Kris Huygen; Ohene Adjei; Dissou Affolabi; Gisela Bretzel; Caroline Demangel; Bernhard Fleischer; Roch Christian Johnson; Jorge Pedrosa; Delphin M Phanzu; Richard O Phillips; Gerd Pluschke; Vera Siegmund; Mahavir Singh; Tjip S van der Werf; Mark Wansbrough-Jones; Françoise Portaels
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.